EVMN
Evommune, Inc.
9.70$
+3.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Evommune, Inc. (EVMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -20 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.8 | -8.6 | -26 | -19 | -24 | -26 | -9.6 | -17 | -28 | -20 | -74 | |
| 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.6 | 1.5 | |
| – | – | 0.4 | 0.5 | – | – | 0.6 | 4.2 | 3.5 | 4.6 | 13 | |
| -2.2 | 18 | -11 | 1.8 | -10.0 | -4.3 | 2.5 | 7.6 | -8.8 | 7.5 | 8.8 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.5 | |
| 9.6 | 10 | – | -33 | 14 | 18 | -24 | -123 | -85 | 31 | -201 | |
| – | – | -0.1 | -0.1 | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.4 | |
| -0.1 | -0.1 | -0.1 | 50 | -0.2 | 64 | -0.3 | 157 | 117 | 0.5 | 274 | |
| 34 | 1.3 | -17 | -1.9 | 5.7 | 56 | -35 | 17 | 4.3 | 12 | -2.0 | |
| -4.9 | -8.6 | -26 | -19 | -24 | -26 | -9.8 | -17 | -28 | -20 | -75 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.